IGF1 and obesity due to melanocortin 4 receptor deficiency: Obesity-induced hyperinsulinemia increases the bioavailability of IGF-1 by reducing the levels of its binding proteins (IGFBP-1 and IGFBP-2), thereby enhancing IGF-1’s mitogenic and anti-apoptotic effects [27].